{"id":"NCT03768427","sponsor":"Organon and Co","briefTitle":"Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)","officialTitle":"A Phase 3 Randomized, Active-comparator-controlled Clinical Study to Evaluate the Efficacy and Safety of Ezetimibe/Atorvastatin Combination Tablet (MK-0653C) as Second Line Lipid Lowering Treatment in Chinese Participants","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-05-27","primaryCompletion":"2021-03-17","completion":"2021-04-01","firstPosted":"2018-12-07","resultsPosted":"2023-02-08","lastUpdate":"2024-05-16"},"enrollment":454,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"EZ 10 mg/Ator 10 mg","otherNames":[]},{"type":"COMBINATION_PRODUCT","name":"EZ 10 mg/Ator 20 mg","otherNames":[]},{"type":"DRUG","name":"Atorvastatin","otherNames":["Lipitor^Â®"]},{"type":"DRUG","name":"Placebo for FDC EZ/Ator","otherNames":[]},{"type":"DRUG","name":"Placebo for atorvastatin","otherNames":[]}],"arms":[{"label":"EZ 10 mg/Ator 10 mg","type":"EXPERIMENTAL"},{"label":"Atorvastatin 20 mg","type":"ACTIVE_COMPARATOR"},{"label":"EZ 10 mg/Ator 20 mg","type":"EXPERIMENTAL"},{"label":"Atorvastatin 40 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the EZ/Ator fixed-dose combination (FDC) tablet (MK-0653C) as second line Low-Density Lipoprotein - Cholesterol (LDL-C) treatment in Chinese participants. The primary hypothesis is that MK-0653C 10/10 mg is superior to atorvastatin 20 mg in percent change from baseline in LDL-C to 12 weeks after treatment.","primaryOutcome":{"measure":"Percent Change From Baseline in LDL-C at Week 12","timeFrame":"Baseline (Day 1) and Week 12","effectByArm":[{"arm":"Atorvastatin 10 mg - Ezetimibe 10 mg/Ator 10 mg","deltaMin":-24.7,"sd":24.9},{"arm":"Atorvastatin 10mg - Atorvastatin 20 mg","deltaMin":-5.3,"sd":22.5},{"arm":"Atorvastatin 20 mg - EZ 10 mg/Ator 20 mg","deltaMin":-23.3,"sd":23.1},{"arm":"Atorvastatin 20 mg - Atorvastatin 40 mg","deltaMin":-9.1,"sd":18.2}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG002 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":28},"locations":{"siteCount":30,"countries":["China"]},"refs":{"pmids":["36182594"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":88},"commonTop":["Alanine aminotransferase increased"]}}